Insurance coverage would expand access for the expensive treatments. The post Medical Insurance Providers Assess Benefits of Psychedelics Treatments appeared...
The article News You Might Have Missed: Dec 5th 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly...
The article Numinus Wellness Reports Q4 2022 and Annual Results was originally published on Microdose. Numinus Wellness Reports Q4 2022 and Annual Results...
DelveInsight’s post-traumatic stress disorder pipeline report depicts a robust space with 25+ active players working to develop 25+ pipeline therapies...
Executive Spotlight: Marco Algorta Beramendi Title: CEO Company: Bienstar Wellness Years at current company: 1 Education profile: Marco is a storytelling...
The article Numinus Launches Ketamine Program for Chronic and Serious Illness was originally published on Microdose. Numinus Launches Psychedelic-Assisted...
Numinus Updates On New Acquisition’s Integration And Provides Client Financing Options Numinus Wellness Inc. (OTCQX: NUMIF) recently acquired psychedelics...
Big money is starting to take a more public interest in the science of psychedelics, which makes even the biggest skeptics take notice. The post Big...